Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study

British Journal of Haematology

Volumn 163, Issue 5, 2013, Pages 603-610

  Farmer, Sarah ^a   Horváth Puhó, Erzsébet ^b   Vestergaard, Hanne ^a   Hermann, Anne Pernille ^a   Frederiksen, Henrik ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronic myeloid leukaemia; Epidemiology; Essential thrombocythaemia; Osteoporosis; Polycythaemia vera

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOPROLIFERATIVE NEOPLASM; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; FEMUR FRACTURE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTHEMIA;

CHRONIC MYELOID LEUKAEMIA; EPIDEMIOLOGY; ESSENTIAL THROMBOCYTHAEMIA; OSTEOPOROSIS; POLYCYTHAEMIA VERA;

ADULT; AGED; ALCOHOL-RELATED DISORDERS; COMORBIDITY; DENMARK; FEMALE; FOLLOW-UP STUDIES; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYCYTHEMIA VERA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SMOKING; THROMBOCYTHEMIA, ESSENTIAL; YOUNG ADULT;

EID: 84887615220     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12581     Document Type: Article

References (29)

1. Barbui, T., Thiele, J., Passamonti, F., Rumi, E., Boveri, E., Ruggeri, M., Rodeghiero, F., d'Amore, E.S., Randi, M.L., Bertozzi, I., Marino, F., Vannucchi, A.M., Antonioli, E., Carrai, V., Gisslinger, H., Buxhofer-Ausch, V., Mullauer, L., Carobbio, A., Gianatti, A., Gangat, N., Hanson, C.A. & Tefferi, A. (2011) Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. Journal of Clinical Oncology, 29, 3179-3184.
2. Barete, S., Assous, N., de Gennes, C., Grandpeix, C., Feger, F., Palmerini, F., Dubreuil, P., Arock, M., Roux, C., Launay, J.M., Fraitag, S., Canioni, D., Billemont, B., Suarez, F., Lanternier, F., Lortholary, O., Hermine, O. & Frances, C. (2010) Systemic mastocytosis and bone involvement in a cohort of 75 patients. Annals of Rheumatic Diseases, 69, 1838-1841.
3. Berman, E., Nicolaides, M., Maki, R.G., Fleisher, M., Chanel, S., Scheu, K., Wilson, B.A., Heller, G. & Sauter, N.P. (2006) Altered bone and mineral metabolism in patients receiving imatinib mesylate. New England Journal of Medicine, 354, 2006-2013.
4. Bjorkholm, M., Ohm, L., Eloranta, S., Derolf, A., Hultcrantz, M., Sjoberg, J., Andersson, T., Hoglund, M., Richter, J., Landgren, O., Kristinsson, S.Y. & Dickman, P.W. (2011) Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. Journal of Clinical Oncology, 29, 2514-2520.
5. Cauley, J.A., Thompson, D.E., Ensrud, K.C., Scott, J.C. & Black, D. (2000) Risk of mortality following clinical fractures. Osteoporosis International, 11, 556-561.
6. Charlson, M.E., Pompei, P., Ales, K.L. & MacKenzie, C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Jounal of Chronic Diseases, 40, 373-383.
7. Frederiksen, H., Farkas, D.K., Christiansen, C.F., Hasselbalch, H.C. & Sorensen, H.T. (2011) Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood, 118, 6515-6520.
8. de Gennes, C., Kuntz, D. & de Vernejoul, M.C. (1992) Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clinical Orthopaedics and Related Research, 279, 281-291.
9. Hasselbalch, H.C. (2012) Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood, 119, 3219-3225.
10. Hochhaus, A., O'Brien, S.G., Guilhot, F., Druker, B.J., Branford, S., Foroni, L., Goldman, J.M., Muller, M.C., Radich, J.P., Rudoltz, M., Mone, M., Gathmann, I., Hughes, T.P. & Larson, R.A. (2009) Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia, 23, 1054-1061.
11. Hultcrantz, M., Kristinsson, S.Y., Andersson, T.M., Landgren, O., Eloranta, S., Derolf, A.R., Dickman, P.W. & Bjorkholm, M. (2012) Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. Jounal of Clinical Oncology, 30, 2995-3001.
12. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (eds.) (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, France.
13. Johnell, O. & Kanis, J.A. (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International, 17, 1726-1733.
14. Johnell, O., Kanis, J.A., Jonsson, B., Oden, A., Johansson, H. & De Laet, C. (2005) The burden of hospitalised fractures in Sweden. Osteoporosis International, 16, 222-228.
15. Jonsson, S., Standal, T., Olsson, B., Mellstrom, D. & Wadenvik, H. (2012) Secondary hyperparathyroidism but stable bone-mineral density in patients with chronic myeloid leukemia treated with imatinib. American Journal of Hematology, 87, 550-552.
16. Kantarjian, H.M., O'Brien, S., Cortes, J., Giles, F.J., Rios, M.B., Shan, J., Faderl, S., Garcia-Manero, G., Ferrajoli, A., Verstovsek, S., Wierda, W., Keating, M. & Talpaz, M. (2003) Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data. Cancer, 98, 2636-2642.
17. Lehmann, T., Beyeler, C., Lammle, B., Hunziker, T., Vock, P., Olah, A.J., Dahinden, C. & Gerber, N.J. (1996) Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. British Journal of Rheumatology, 35, 898-900.
18. Lynge, E., Sandegaard, J.L. & Rebolj, M. (2011) The Danish National Patient Register. Scandinavian Journal of Public Health, 39, 30-33.
19. Metcalfe, D.D. (2008) Mast cells and mastocytosis. Blood, 112, 946-956.
20. Norgaard, M., Skriver, M.V., Gregersen, H., Pedersen, G., Schonheyder, H.C. & Sorensen, H.T. (2005) The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry. European Journal of Cancer Prevention, 14, 201-206.
21. O'Sullivan, S., Naot, D., Callon, K.E., Watson, M., Gamble, G.D., Ladefoged, M., Karsdal, M.A., Browett, P., Cornish, J. & Grey, A. (2011) Imatinib mesylate does not increase bone volume in vivo. Calcified Tissue International, 88, 16-22.
22. O'Sullivan, S., Horne, A., Wattie, D., Porteous, F., Gamble, G., Browett, P. & Grey, A. (2013) Bone metabolism during long-term treatment with imatinib. Leukemia and Lymphoma, 54, 1783-1785.
23. Pardanani, A. (2012) Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. American Journal of Hematology, 87, 401-411.
24. Pedersen, C.B. (2011) The Danish Civil Registration System. Scandinavian Journal of Public Health, 39, 22-25.
25. Poole, K.E. & Compston, J.E. (2006) Osteoporosis and its management. British Medical Journal, 333, 1251-1256.
26. Tefferi, A. (2012) Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology, 87, 285-293.
27. Thygesen, S.K., Christiansen, C.F., Christensen, S., Lash, T.L. & Sorensen, H.T. (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Medical Research Methodology, 11, 83.
28. van der Veer, E., van der Goot, W., de Monchy, J.G., Kluin-Nelemans, H.C. & van Doormaal, J.J. (2012) High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. Allergy, 67, 431-438.
29. Weide, R., Ehlenz, K., Lorenz, W., Walthers, E., Klausmann, M. & Pfluger, K.H. (1996) Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Annals of Hematology, 72, 41-43.